Price increase of geriatric drugs in the U.S. in 2017, by manufacturer

Average price increase of brand name drugs widely used by older adults in the U.S. as of 2017, by manufacturer*

by Matej Mikulic, last edited Mar 29, 2019
Price increase of geriatric drugs in the U.S. in 2017, by manufacturer This statistic depicts the average price increase of brand name drugs widely used by older adults in the U.S. during 2017, by manufacturer. According to the source, Astellas had four drugs that increased in price by an average of 17 percent during 2017.
Show more

Average price increase of brand name drugs widely used by older adults in the U.S. as of 2017, by manufacturer*

Loading statistic...
Expand statistic
Manufacturer (number of drugs)Price increase
PCCA (3)269.2%
Astellas (4)17%
Sankyo (11)14.3%
Pfizer U.S. (24)13.8%
Lundbeck (2)11.4%
Aptalis Pharma (2)9.3%
Cephalon (2)9.2%
Shire US Inc. (2)9.1%
Purdue Pharma L.P. (6)8.8%
Merck/Schering-Plough Pharm (4)8.5%
Actavis (17)8.4%
Allergan (4)8.1%
Horizon Pharma (2)8%
Janssen (10)7.4%
Merck Sharp and Dohme (13)7.4%
Alcon Vision (8)7.3%
Amgen (3)7%
Novartis (16)6.9%
UCB Pharma (2)6.8%
Genentech (5)6.6%
Boehringer Ingelheim (8)6.5%
Valent (12)6.1%
Gilead Sciences (2)5.9%
Lilly (10)5.8%
AbbVie (13)5.4%
All others (13)5.2%
Glaxo Smith Kline (13)5.2%
Teva (3)4.7%
Endo Pharmaceuticals (2)4.4%
Takeda Pharmaceuticals (5)4%
Novo Nordisk (8)3.8%
Sanofi-Aventis U.S. (4)2.8%
Sunovion Pharmaceucticals (4)2.6%
AstraZeneca (19)2.6%
Bristo-Myers Squibb (9)0.8%
Genzyme (2)-1.9%
Manufacturer (number of drugs)Price increase
PCCA (3)269.2%
Astellas (4)17%
Sankyo (11)14.3%
Pfizer U.S. (24)13.8%
Lundbeck (2)11.4%
Aptalis Pharma (2)9.3%
Cephalon (2)9.2%
Shire US Inc. (2)9.1%
Purdue Pharma L.P. (6)8.8%
Merck/Schering-Plough Pharm (4)8.5%
Actavis (17)8.4%
Allergan (4)8.1%
Horizon Pharma (2)8%
Janssen (10)7.4%
Merck Sharp and Dohme (13)7.4%
Alcon Vision (8)7.3%
Amgen (3)7%
Novartis (16)6.9%
UCB Pharma (2)6.8%
Genentech (5)6.6%
Boehringer Ingelheim (8)6.5%
Valent (12)6.1%
Gilead Sciences (2)5.9%
Lilly (10)5.8%
AbbVie (13)5.4%
All others (13)5.2%
Glaxo Smith Kline (13)5.2%
Teva (3)4.7%
Endo Pharmaceuticals (2)4.4%
Takeda Pharmaceuticals (5)4%
Novo Nordisk (8)3.8%
Sanofi-Aventis U.S. (4)2.8%
Sunovion Pharmaceucticals (4)2.6%
AstraZeneca (19)2.6%
Bristo-Myers Squibb (9)0.8%
Genzyme (2)-1.9%
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Mar 29, 2019
This statistic depicts the average price increase of brand name drugs widely used by older adults in the U.S. during 2017, by manufacturer. According to the source, Astellas had four drugs that increased in price by an average of 17 percent during 2017.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.